Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

2.

Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients.

Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK.

World J Diabetes. 2017 Mar 15;8(3):112-119. doi: 10.4239/wjd.v8.i3.112.

3.

Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries.

Aldukhayel A.

Int J Health Sci (Qassim). 2017 Jan-Mar;11(1):1-4. Review.

4.

Diabetic kidney disease: world wide difference of prevalence and risk factors.

Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T.

J Nephropharmacol. 2015 Oct 9;5(1):49-56. eCollection 2016. Review.

5.

Interpretation of metabolic memory phenomenon using a physiological systems model: What drives oxidative stress following glucose normalization?

Voronova V, Zhudenkov K, Helmlinger G, Peskov K.

PLoS One. 2017 Feb 8;12(2):e0171781. doi: 10.1371/journal.pone.0171781. eCollection 2017.

6.

Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-β/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues.

Xu ZJ, Shu S, Li ZJ, Liu YM, Zhang RY, Zhang Y.

Medicine (Baltimore). 2017 Jan;96(3):e5879. doi: 10.1097/MD.0000000000005879.

7.

The Leaf of Diospyros kaki Thumb Ameliorates Renal Oxidative Damage in Mice with Type 2 Diabetes.

Choi MS, Jeong MJ, Park YB, Kim SR, Jung UJ.

Prev Nutr Food Sci. 2016 Dec;21(4):378-383. doi: 10.3746/pnf.2016.21.4.378. Epub 2016 Dec 31.

8.

Sodium and Its Role in Cardiovascular Disease - The Debate Continues.

Kong YW, Baqar S, Jerums G, Ekinci EI.

Front Endocrinol (Lausanne). 2016 Dec 23;7:164. doi: 10.3389/fendo.2016.00164. eCollection 2016. Review.

9.

Effect of vitamin D on proteinuria in type 2 diabetic patients.

Momeni A, Mirhosseini M, Kabiri M, Kheiri S.

J Nephropathol. 2017 Jan;6(1):10-14. doi: 10.15171/jnp.2017.03. Epub 2016 Aug 14.

10.

Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).

Mondesir FL, Brown TM, Muntner P, Durant RW, Carson AP, Safford MM, Levitan EB.

Am Heart J. 2016 Nov;181:43-51. doi: 10.1016/j.ahj.2016.08.002. Epub 2016 Aug 12.

PMID:
27823692
11.

Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).

Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, Sugimoto H, Kurihara Y, Araki SI, Maegawa H.

BMJ Open Diabetes Res Care. 2016 Oct 3;4(1):e000294. eCollection 2016.

12.

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin-Angiotensin-Aldosterone System Blockers.

Ueda Y, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Hirai K, Kaku Y, Mori H, Hoshino T, Ookawara S, Kakei M, Tabei K, Morishita Y.

Drug Target Insights. 2016 Sep 11;10:13-8. doi: 10.4137/DTI.S38339. eCollection 2016.

13.

Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.

Cheng R, Ding L, He X, Takahashi Y, Ma JX.

Diabetes. 2016 Dec;65(12):3730-3743. Epub 2016 Aug 19.

PMID:
27543085
14.

Autophagy in Chronic Kidney Diseases.

Liu N, Shi Y, Zhuang S.

Kidney Dis (Basel). 2016 Apr;2(1):37-45. doi: 10.1159/000444841. Epub 2016 Mar 24. Review.

15.

Recent Progress in Stem Cell Therapy for Diabetic Nephropathy.

Liu Y, Tang SC.

Kidney Dis (Basel). 2016 Apr;2(1):20-7. doi: 10.1159/000441913. Epub 2015 Dec 5. Review.

16.

Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.

Miranda-Díaz AG, Pazarín-Villaseñor L, Yanowsky-Escatell FG, Andrade-Sierra J.

J Diabetes Res. 2016;2016:7047238. doi: 10.1155/2016/7047238. Epub 2016 Jul 20. Review.

17.

An additive effect of anti-PAI-1 antibody to ACE inhibitor on slowing the progression of diabetic kidney disease.

Gu C, Zhang J, Noble NA, Peng XR, Huang Y.

Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F852-F863. doi: 10.1152/ajprenal.00564.2015. Epub 2016 Aug 10.

PMID:
27511457
18.

Development of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes.

Morris JL, Bridson TL, Alim MA, Rush CM, Rudd DM, Govan BL, Ketheesan N.

Biol Open. 2016 Aug 15;5(8):1149-62. doi: 10.1242/bio.016790.

19.

Effect of angiotensin converting enzyme inhibitor on glomerular hyperfiltration in patients with type 1 diabetes.

Naqvi SA, Ahsan S, Fawwad A, Basit A, Shera AS.

Pak J Med Sci. 2016 May-Jun;32(3):559-64. doi: 10.12669/pjms.323.9399.

20.

A pilot trial to examine the association between circulating endothelial cell levels and vascular injury in patients with diabetes and chronic kidney disease.

Shirazian S, Grant C, Rambhujun V, Sharma R, Patel R, Islam S, Mattana J.

F1000Res. 2016 Mar 7;5:292. doi: 10.12688/f1000research.8005.1. eCollection 2016.

Supplemental Content

Support Center